Tag Archives: hep C

August, 2017

July, 2017

April, 2017

February, 2017

  • 22 February

    The 2017 Hepatitis C Treatment Landscape

    Last year, 2016, brought a whirlwind of changes and progress to the hepatitis C field, particularly when it comes to direct-acting antiviral medications. This included various drug approvals and access improvements for hepatitis C medications, including Daklinza, Epclusa, Sovaldi/velpatasvir, Viekira, and Zepatier. As we make our way deeper into 2017, …

  • 15 February

    Understanding the Hepatitis C Testing Process

    Many of your patients will likely need to be screened for hepatitis C, which means that they will have many questions during the testing process. This blog geared to patient education can help your patients understand each step of what can be a stressful time in their lives. Q: Do …

  • 3 February

    AbbVie’s Hepatitis C Treatment Receives Priority Review from the FDA

    NORTH CHICAGO, Ill., Feb. 2, 2017 /PRNewswire/ — AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) and granted priority review for its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P), being evaluated for the treatment of all …

January, 2017

  • 25 January

    HCV: Relapse or Reinfection?

    Today’s hepatitis C medications offer extremely high cure rates. In fact, the few cases of a previously treated patient later testing positive for hepatitis C has some patients wondering “did I relapse or could I have been reinfected?” There are six different genotypes of the hepatitis C virus (as well …

December, 2016